Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 224

1.

Multiple tumor suppressor pathways negatively regulate telomerase.

Lin SY, Elledge SJ.

Cell. 2003 Jun 27;113(7):881-9.

2.

Induction of endogenous telomerase (hTERT) by c-Myc in WI-38 fibroblasts transformed with specific genetic elements.

Casillas MA, Brotherton SL, Andrews LG, Ruppert JM, Tollefsbol TO.

Gene. 2003 Oct 16;316:57-65.

PMID:
14563552
3.
4.
5.

Early upregulation of cyclooxygenase-2 in human papillomavirus type 16 and telomerase-induced immortalization of human esophageal epithelial cells.

Zhuang ZH, Tsao SW, Deng W, Wang JD, Xia HH, He H, Feng HC, Wang LD, Gu Q, Lam SK, Lin MC, Kung HF, Wong BC.

J Gastroenterol Hepatol. 2008 Oct;23(10):1613-20. doi: 10.1111/j.1440-1746.2008.05509.x. Epub 2008 Aug 20.

PMID:
18717758
6.

Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms.

Horikawa I, Barrett JC.

Carcinogenesis. 2003 Jul;24(7):1167-76. Epub 2003 May 22. Review.

PMID:
12807729
7.
8.

IFN-gamma/IRF-1-induced p27kip1 down-regulates telomerase activity and human telomerase reverse transcriptase expression in human cervical cancer.

Lee SH, Kim JW, Oh SH, Kim YJ, Rho SB, Park K, Park KL, Lee JH.

FEBS Lett. 2005 Feb 14;579(5):1027-33. Epub 2005 Jan 13. Erratum in: FEBS Lett. 2005 Nov 7;579(27):6288.

9.
10.

Effect of oncogene expression on telomerase activation and telomere length in human endothelial, fibroblast and prostate epithelial cells.

Burger AM, Fiebig HH, Kuettel MR, Lautenberger JA, Kung HF, Rhim JS.

Int J Oncol. 1998 Nov;13(5):1043-8.

PMID:
9772298
11.

Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.

Choe C, Chen N, Sawadogo M.

Exp Cell Res. 2005 Jan 1;302(1):1-10.

PMID:
15541720
12.

Unraveling human tumor suppressor pathways: a tale of the INK4A locus.

Voorhoeve PM, Agami R.

Cell Cycle. 2004 May;3(5):616-20. Epub 2004 May 15. Review.

PMID:
15044859
13.

MEN1 tumor-suppressor protein localizes to telomeres during meiosis.

Suphapeetiporn K, Greally JM, Walpita D, Ashley T, Bale AE.

Genes Chromosomes Cancer. 2002 Sep;35(1):81-5.

PMID:
12203793
14.

Identification of Mad as a repressor of the human telomerase (hTERT) gene.

Oh S, Song YH, Yim J, Kim TK.

Oncogene. 2000 Mar 9;19(11):1485-90.

15.
16.

Telomere maintenance and cell cycle regulation in spontaneously immortalized T-cell lines from Nijmegen breakage syndrome patients.

Siwicki JK, Degerman S, Chrzanowska KH, Roos G.

Exp Cell Res. 2003 Jul 1;287(1):178-89.

PMID:
12799193
17.

Immortal ALT+ human cells do not require telomerase reverse transcriptase for malignant transformation.

Sun B, Chen M, Hawks CL, Hornsby PJ.

Cancer Res. 2005 Aug 1;65(15):6512-5.

18.

Telomeres, telomerase, and myc. An update.

Cerni C.

Mutat Res. 2000 Jan;462(1):31-47. Review.

PMID:
10648922
19.

Knockdown of p53 combined with expression of the catalytic subunit of telomerase is sufficient to immortalize primary human ovarian surface epithelial cells.

Yang G, Rosen DG, Mercado-Uribe I, Colacino JA, Mills GB, Bast RC Jr, Zhou C, Liu J.

Carcinogenesis. 2007 Jan;28(1):174-82. Epub 2006 Jul 8.

PMID:
16829690
20.

Repression of in vivo growth of Myc/Ras transformed tumor cells by Mad1.

Cerni C, Skrzypek B, Popov N, Sasgary S, Schmidt G, Larsson LG, L├╝scher B, Henriksson M.

Oncogene. 2002 Jan 17;21(3):447-59.

Supplemental Content

Support Center